- Exchange: Xetra
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Whsle Drug Dist
Snapshot for Celesio AG (CLS1)
| Open: | 16.050 | Day's Range: | 15.715 - 16.270 | Volume: | 1,077,589 |
|---|---|---|---|---|---|
| Previous Close: | 16.605 | 52wk Range: | 10.720 - 16.785 | 1-Yr Rtn: | +37.75% |
Key Statistics for CLS1
| Current P/E Ratio (ttm) | 27.0847 |
|---|---|
| Estimated P/E(12/2013) | 12.6424 |
| Relative P/E vs. DAX | 1.6970 |
| Earnings Per Share (EUR) (ttm) | 0.5900 |
| Est. EPS (EUR) (12/2013) | 1.2640 |
| Est. PEG Ratio | 1.1321 |
| Market Cap (M EUR) | 2,718.20 |
| Shares Outstanding (M) | 170.10 |
| 30 Day Average Volume | 530,412 |
| Price/Book (mrq) | 1.2395 |
| Price/Sale (ttm) | 0.1236 |
| Dividend Indicated Gross Yield | 1.87% |
| Cash Dividend (EUR) | 0.3000 |
| Last Dividend | 05/17/2013 |
| 5 Year Dividend Growth | -17.18% |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CLS1
Company Profile & Key Executives for CLS1
Celesio AG wholesales and retails pharmaceuticals to customers in Europe. The Company wholesales pharmaceuticals, operates retail pharmacies, and provides logistics and transportation services for pharmaceuticals at local, national and European level.
| Markus PingerChairman-Mgmt Board/CEO | Marion M HelmesCFO/Member-Mgmt Board |
| Stephan BorchertMember-Mgmt Board | Sabine GottgensDirector:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CLS1 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page